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Motor neuron loss is a feature of amyotrophic lateral sclerosis (ALS), spinal mus-
cle atrophy (SMA) and it is recently described in other neurodegenerative disorders. 
In humans these disorders vary from dramatically short up to long disease duration. 
A short disease duration in humans ranges from some months up to 1 or 2 years. 
In contrast animal models commonly used to evaluate motor neuron disorders are 
extremely short lasting, where motor impairment lasts about a few weeks. This is 
the case of the G93A mouse model which is expected to reproduce ALS in humans. 
Despite commonalities, this condensed time interval is likely to produce different 
pathological correlates. Therefore, it is not surprising that experimental morphol-
ogy and therapeutics fail to detect some hallmarks of human disorders in these ani-
mal models. This temporal discrepancy is often missed out and genetic background 
as well as evolution-based structural differences in motor systems are considered as 
critical determinants instead. The present communication wish to introduce the ben-
efits of a long-lasting animal model of motor neuron disorders. In detail, we had been 
able to characterize the motor failure, the biochemical abnormalities and the morpho-
logical alterations which develop only at prolonged time interval (18 months) using a 
single knock out double transgenic mouse model of human SMAIII.
In these mice we had been able to dissect for the first time morphological altera-
tions typical of human disorders such as motor neuron heterotopy as well as motor 
neuron loss. This is correlated with a profound loss of the survival motor neuron 
(SMN) protein. There was a remarkable somatotopic correlation between the spe-
cific motor deficit (proximal vs distal limb muscles) and the severity of motor neu-
ron loss in the corresponding pool (medial vs lateral) of motor neurons in the spinal 
cord. This ideal experimental context provides the chance to evaluate the therapeutic 
effects of specific drugs administered in the long run ruling out bias due to experi-
mental variability when the drugs are administered only for a few weeks. In this way 
it is also easy to discern symptomatic vs disease modifying effects.
In line with this, we compared the effects of GSK3 beta inhibitors and/or 
autophagy activators and we found a remarkable induction in the SMN protein 
which was in line with protection from motor neuron loss and a steady effect coun-
teracting the long term progressive motor deterioration.
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